A clinical study on effectiveness of Bhramari pranayama in prevention of perimenopausal syndrome.

A single arm clinical study on effectiveness of Bhramari Pranayama in prevention of perimenopausal syndrome.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035666

Enrollment

Registered

2021-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bhramari pranayama: it is a type of Pranayama.simple Bhramari pranayama is the action of making a light humming sound while exhalation.it will be conducted in presence of expert yoga te

4 sessions/week. Intervention2: Bhramari Pranayam: Simple bhramari pranayam is the action of making a light humming sound while exhalation. Intervention3: bhramari pranayama: bhramari pranayama is mak

4 sessions/week. Intervention10: NIL: NIL Control Intervention1: NIL: NIL Control Intervention2: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: women having clinical features of perimenopausal syndrome according to menopausal rating scale.

Exclusion criteria

Exclusion criteria: 1.Subjects with known case of malignancy. 2.surgical menopause 3.subjects suffering from major systemic illness necessitating long term drug treatment 4.k/c/o rheumatoid arthritis,psycho-neuro-Endocrinol disorders 5.subjects with clinical evidence of heart failure.

Design outcomes

Primary

Measure	Time frame
A single arm clinical study to evaluate effectiveness of Bhramari Pranayama in Prevention of Perimenopausal syndrome.Parameter of efficacy will be Questionnaire according to Menopause Rating Scale.Timepoint: The treatment will be given for 60 days.Patients will be assessed on 15th day,30th day,45th day,60th day of the treatment.Total duration of the study will be 2 months.	—

Secondary

Measure	Time frame
The secondary outcome will be prevention of Menopausal Syndrome.Timepoint: The treatment will be given for 60 days.Patients will be assessed on 15th day,30th day,45th day,60th day.Total duration of the study will be 2 months.	—

Countries

India

Contacts

Public ContactDrRamesh Ujwale

Sumatibhai shah ayurved Mahavidyalaya Hadapsar pune

ujwale_rs@rediffmail.com9922008027

Outcome results